搜尋
Elanco Animal Health Inc
ELAN添加自選
23.650USD
-0.365-1.52%
收盤 05/08, 16:00（美東）報價延遲15分鐘
11.81B總市值
虧損本益比TTM
關於 Elanco Animal Health Inc 公司
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Elanco Animal Health Inc簡介
公司代碼ELAN
公司名稱Elanco Animal Health Inc
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)
員工數量9000
證券類型Ordinary Share
年結日Sep 20
公司地址450 Elanco Circle
城市INDIANAPOLIS
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編46221
電話18773526261
網址https://www.elanco.com/
公司代碼ELAN
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)
Elanco Animal Health Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
170.34K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
--
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
--
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
84.81K
--
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
170.34K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
--
收入明細
單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Farm Animal
2.36B
50.10%
Pet Health
2.30B
48.78%
Contract Manufacturing
53.00M
1.12%
地區USD
名稱
營收
佔比
International
2.48B
52.62%
United States
2.23B
47.38%
業務
地區
業務USD
名稱
營收
佔比
Farm Animal
2.36B
50.10%
Pet Health
2.30B
48.78%
Contract Manufacturing
53.00M
1.12%
股東統計
更新時間: 11 小時前
更新時間: 11 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Dodge & Cox
15.83%
PRIMECAP Management Company
9.25%
BlackRock Institutional Trust Company, N.A.
8.17%
Fidelity Management & Research Company LLC
7.82%
T. Rowe Price Investment Management, Inc.
7.05%
其他
51.87%
持股股東
持股股東
佔比
Dodge & Cox
15.83%
PRIMECAP Management Company
9.25%
BlackRock Institutional Trust Company, N.A.
8.17%
Fidelity Management & Research Company LLC
7.82%
T. Rowe Price Investment Management, Inc.
7.05%
其他
51.87%
股東類型
持股股東
佔比
Investment Advisor
74.55%
Investment Advisor/Hedge Fund
36.56%
Hedge Fund
4.40%
Research Firm
1.99%
Individual Investor
1.29%
Pension Fund
1.13%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.29%
Family Office
0.12%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
950
549.30M
109.98%
-60.07M
2025Q4
852
577.24M
120.43%
+30.91K
2025Q3
891
577.57M
121.95%
+32.95M
2025Q2
878
543.55M
113.98%
+36.20M
2025Q1
945
503.90M
116.31%
-73.53M
2024Q4
964
498.16M
117.36%
+7.74M
2024Q3
970
490.73M
118.81%
+19.54K
2024Q2
1004
491.01M
118.24%
+1.27M
2024Q1
1021
489.85M
119.72%
-100.34M
2023Q4
1018
489.74M
120.73%
-3.72M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Dodge & Cox
79.08M
15.91%
-3.68M
-4.44%
Dec 31, 2025
PRIMECAP Management Company
46.21M
9.3%
-3.74M
-7.49%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
40.81M
8.21%
+388.49K
+0.96%
Dec 31, 2025
Fidelity Management & Research Company LLC
39.05M
7.86%
-11.69M
-23.03%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
35.23M
7.09%
+3.72M
+11.80%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
25.08M
5.05%
+373.87K
+1.51%
Dec 31, 2025
State Street Investment Management (US)
15.05M
3.03%
-195.25K
-1.28%
Dec 31, 2025
Fidelity Institutional Asset Management
12.16M
2.45%
-67.80K
-0.55%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares U.S. Pharmaceuticals ETF
4.06%
Adaptiv Select ETF
3.38%
State Street SPDR S&P Pharmaceuticals ETF
3.15%
Brandes US Small-Mid Cap Value ETF
3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.84%
VanEck Agribusiness ETF
2.3%
First Trust Health Care Alphadex Fund
1.92%
Federated Hermes MDT Large Cap Value ETF
1.9%
First Trust NASDAQ Pharmaceuticals ETF
1.33%
Invesco S&P MidCap 400 Pure Value ETF
1.22%
查看更多
iShares U.S. Pharmaceuticals ETF
佔比4.06%
Adaptiv Select ETF
佔比3.38%
State Street SPDR S&P Pharmaceuticals ETF
佔比3.15%
Brandes US Small-Mid Cap Value ETF
佔比3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比2.84%
VanEck Agribusiness ETF
佔比2.3%
First Trust Health Care Alphadex Fund
佔比1.92%
Federated Hermes MDT Large Cap Value ETF
佔比1.9%
First Trust NASDAQ Pharmaceuticals ETF
佔比1.33%
Invesco S&P MidCap 400 Pure Value ETF
佔比1.22%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
